The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 1 - 10 of 24
Uganda PrEP Ring Stakeholder Consultations Summary
This country-level analysis from Uganda shares key stakeholder perceptions of the ring and is the product of consultations led by WHO, IPM, and MOSAIC during the period December 2021 – March 2022.
Uganda’s COP 2021
The goal of Uganda’s 2021 Country Operational Plan is to maintain progress from 2020 in key areas related to health promotion such as refining efforts to eliminate policy barriers, insitutionalizing client- centered services, helping the country achieve 95-95-95, and spotlighting HIV prevention and treatment access for all populations in need.
Uganda Monitoring & Evaluation Plan 2020-25
Having come close to achieving 95:95:95 by 2020, Uganda launched an set of two plans to achieve 95:95:95 in the coming decade, with a special focus on children. The first plan is the National HIV and AIDS Strategic Plan and the second is this Monitoring and Evaluation Plan (M&E Plan). This M&E Plan seeks to…
HOPE Protocol Team Meeting Lessons Learned from PrEP Rollout for the Dapivirine Ring
This presentation outlines lessons from oral PrEP demonstration projects that could be applied to the rollout of the dapivirine vaginal ring as well as plans for ring introduction.
Use of the Dapivirine vaginal ring and effect on cervical cytology abnormalities
This study aims to determine if the dapivirine vaginal ring and the ring device alone (flexible silicone matrix polymer) was associated with the development of cervical cytology abnormalities.
Implementation Research, Service Delivery
Microbicide Trials Network-043 – B-PROTECTED Study
This page explains the Microbicide Trials Network (MTN) 043 study, which evaluated the safety and acceptability of the dapivirine vaginal ring and oral PrEP in people who are breastfeeding. The page includes videos explaining the study in Chichewa, Luganda, Shona, and Zulu.
Microbicide Trials Network-042 – DELIVER Study
This page explains the Microbicide Trials Network (MTN) 042 study, which evaluated the safety and acceptability of the dapivirine vaginal ring and oral PrEP in people who are pregnant. The page includes videos explaining the study in Chichewa, Luganda, Shona, and Zulu.
Adherence to the Dapivirine vaginal ring and oral PrEP among adolescent girls and young women in Africa: interim results from the REACH study